Published in Acta Chir Scand on April 01, 1987
Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother (1994) 1.48
Which groups of patients benefit from helicopter evacuation? Lancet (1996) 2.83
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A (1977) 2.79
Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA (1999) 2.71
Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost (1983) 1.96
Blood borne tissue factor revisited. Thromb Res (2007) 1.65
Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry (1970) 1.62
The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol (1982) 1.51
Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood (1977) 1.50
Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb Haemost (1993) 1.45
Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagul Fibrinolysis (1994) 1.45
Hemophilia B: characterization of genetic variants and detection of carriers. Blood (1977) 1.20
The inflammatory properties of contained and noncontained lumbar disc herniation. Spine (Phila Pa 1976) (1997) 1.19
Formation of intrinsic factor-X activator activity, with special reference to the role of thrombin. Br J Haematol (1971) 1.16
The effect of short-term cold exposure on risk factors for cardiovascular disease. Thromb Res (1999) 1.15
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J (Clin Res Ed) (1984) 1.14
Quantitation of endotoxin in blood from patients with meningococcal disease using a limulus lysate test in combination with chromogenic substrate. Infection (1983) 1.13
Purification and some characteristics of the coagulation factor IX from human plasma. Biochem J (1975) 1.12
Macrophages produce blood coagulation factors. FEBS Lett (1980) 1.07
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood (1979) 1.07
Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol (1993) 1.06
Electroimmunoassay of factor IX in hemophilia B. Thromb Res (1975) 1.05
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest (1979) 1.04
Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry (1972) 1.03
Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost (2000) 1.01
Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem (1978) 0.99
The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost (1976) 0.98
Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol (1984) 0.97
Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation (1993) 0.96
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction. Am J Cardiol (1989) 0.95
Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett (1981) 0.93
Gel filtration properties of factors II, VII, IX, IX a , and X. Thromb Diath Haemorrh (1972) 0.93
A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol (1995) 0.93
Biphasic changes in leukocytes induced by strenuous exercise. Eur J Appl Physiol Occup Physiol (1991) 0.92
The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin. Biochem J (1974) 0.90
The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett (1982) 0.89
Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J (1982) 0.89
The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med (1999) 0.89
Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system. Thromb Res (1974) 0.89
Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state? Hum Reprod (1991) 0.87
Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Scand J Haematol (1980) 0.87
Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemost (1997) 0.86
C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients. Scand J Immunol (1995) 0.85
Inhibition of the thrombin-fibrinogen reaction by a macromolecular factor from rat liver. Biochem J (1972) 0.85
Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res (1978) 0.85
Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids (1998) 0.85
Cost savings and health losses from reducing inappropriate admissions to a department of internal medicine. Int J Technol Assess Health Care (2000) 0.84
Multiply beta-lactam resistant Enterobacter cloacae infections linked to the environmental flora in a unit for cardiothoracic and vascular surgery. Scand J Infect Dis (1989) 0.84
Mononuclear phagocyte thromboplastin, bacterial counts and endotoxin levels in experimental endogenous gram-negative sepsis. Acta Chir Scand (1986) 0.84
Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Prog Clin Biol Res (1988) 0.84
The production of tumour necrosis factor, tissue thromboplastin, lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood. Scand J Clin Lab Invest (1990) 0.84
Enhanced endothelium-dependent vasodilatation in human skin vasculature induced by physical conditioning. Eur J Appl Physiol Occup Physiol (1998) 0.83
Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary bacterial peritonitis. Scand J Gastroenterol (1987) 0.83
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor. Thromb Haemost (1981) 0.82
The development of monospecific antibodies against human thromboplastin apoprotein (apoprotein III) and their application in the immunocytochemical detection of the antigen in blood cells. Thromb Res (1987) 0.82
Postinfarction left ventricular pseudoaneurysm--echocardiographic diagnosis and surgical repair. Cardiovasc Surg (1994) 0.82
Experimental gram-negative septicemia: thromboplastin generation in mononuclear phagocytes from different anatomical sites. Thromb Res (1987) 0.81
Activation pathways of the coagulation system in normal haemostasis. Scand J Haematol (1984) 0.81
Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemost (1990) 0.80
Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules. Thromb Res (1979) 0.80
Evidence for exclusive role of the p55 tumor necrosis factor (TNF) receptor in mediating the TNF-induced collagenase expression by human dermal fibroblasts. J Invest Dermatol (1996) 0.80
Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thromb Haemost (1991) 0.80
Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins. Blood Coagul Fibrinolysis (1990) 0.79
Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII. Blood (1978) 0.79
A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids (2001) 0.79
Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol (1984) 0.79
Factor VIIa in patients with C1-inhibitor deficiency. Thromb Haemost (1995) 0.79
Thromboplastin activity of blood monocytes after total hip replacement. Scand J Clin Lab Invest (1990) 0.79
The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X. Scand J Haematol (1975) 0.78
Immunological studies on the blood coagulation Factor X and its warfarin-induced precursor. Thromb Diath Haemorrh (1974) 0.78
Processing of marine foods. Meat Sci (1996) 0.78
Tissue thromboplastin generation in circulating mononuclear phagocytes and development of coagulation disorders during E. coli endotoxinaemia in pigs. Acta Chir Scand (1985) 0.78
Experimental gram-negative peritonitis: decreased thromboplastin activity in organs with a simultaneous rise of thromboplastin in blood monocytes and peritoneal macrophages. Res Exp Med (Berl) (1986) 0.78
Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol (1995) 0.78
The effect of melatonin on cellular activation processes in human blood. J Pineal Res (1999) 0.78
Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol (1985) 0.78
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation? J Thromb Haemost (2006) 0.78
Evidence against collagen activation of platelet-associated factor XI as a mechanism for initiating intrinsic clotting. Scand J Haematol (1979) 0.78
The effect of factor IX and factor X on blood platelets. Scand J Haematol (1974) 0.77
Platelet storage lesion: formation of platelet fragments with platelet factor 3 activity. Thromb Res (1987) 0.77
Heparin for infants and children with meningococcal septicemia. Results of a randomized therapeutic trial. NIPH Ann (1983) 0.77
How to measure factor VII and factor VII activation. Haemostasis (1983) 0.77
Tissue factor expression in monocytes: in vitro compared to ex vivo. Thromb Haemost (2000) 0.77
A new protective solution for hypothermic storage of free vein grafts in cardiovascular surgery. Scand J Clin Lab Invest (1992) 0.77
The role of complement in the induction of thromboplastin synthesis. Haemostasis (1984) 0.77
Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis (1993) 0.76
Protection by aminated glucan in experimental endogenous peritonitis. Eur Surg Res (1987) 0.76
Lipopolysaccharide induced monocyte thromboplastin synthesis and coagulation responses in patients undergoing coronary bypass surgery after preoperative supplementation with n-3 fatty acids. Thromb Haemost (1993) 0.76
TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells. Thromb Haemost (2000) 0.76
Effects of ethanol on human blood fibrinolysis and coagulation. Alcohol Alcohol Suppl (1987) 0.76
Changes in blood cell response following strenuous physical exercise. Eur J Appl Physiol Occup Physiol (1992) 0.76
Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med Suppl (1989) 0.76
Thromboplastin activity in amniotic fluid. Gynecol Obstet Invest (1985) 0.76
Cellular activation in response to physical exercise: the effect of platelets and granulocytes on monocyte reactivity. Blood Coagul Fibrinolysis (1998) 0.76
Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets. Thromb Res (1983) 0.76
Some characteristics of the Coagulation Factor Xa purified from human serum. Biochem J (1973) 0.76
The effect of splenectomy on Escherichia coli sepsis and its treatment with semisoluble aminated glucan. Scand J Gastroenterol (1987) 0.76
High tissue factor-expressing human monocytes carry low surface CD36: application to intersubject variability. J Thromb Haemost (2007) 0.76